These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7477641)

  • 21. Successful treatment with a novel immunosuppressive agent, deoxyspergualin, in type II collagen-induced arthritis in mice.
    Nemoto K; Mae T; Abe F; Takeuchi T
    Ann N Y Acad Sci; 1993 Jun; 685():148-54. PubMed ID: 8363219
    [No Abstract]   [Full Text] [Related]  

  • 22. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
    Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine.
    Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical application of 15-deoxyspergualin for treatment of acute graft rejection following renal transplantation.
    Suzuki S; Hayashi R; Kenmochi T; Shimatani K; Fukuoka T; Amemiya H
    Transplant Proc; 1990 Aug; 22(4):1615-7. PubMed ID: 2389422
    [No Abstract]   [Full Text] [Related]  

  • 25. 15-Deoxyspergualin after cardiac and renal allotransplantation in primates.
    Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Schorlemmer HU; Reichart B
    Transplant Proc; 1990 Aug; 22(4):1618-9. PubMed ID: 2389423
    [No Abstract]   [Full Text] [Related]  

  • 26. Addition of deoxyspergualin to standard triple immunosuppressive regimen in kidney transplantation.
    Seki T; Tanda K; Chikaraishi T; Takeuchi I; Kanagawa K; Togashi M; Koyanagi T
    Transplant Proc; 1996 Jun; 28(3):1352-3. PubMed ID: 8658690
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness of 15-deoxyspergualin on renal graft rejection.
    Kozaki K; Matsuno N; Sakurai E; Tamaki I; Furuhashi K; Saito A; Yoshida M; Miyamoto K; Kozaki M
    Transplant Proc; 1994 Aug; 26(4):1903-4. PubMed ID: 8066619
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of acute rejection episodes and induction of tolerance in rat skin allotransplantation by 15-deoxyspergualin.
    Schorlemmer HU; Dickneite G; Seiler FR
    Transplant Proc; 1990 Aug; 22(4):1626-30. PubMed ID: 2389427
    [No Abstract]   [Full Text] [Related]  

  • 29. 15-Deoxyspergualin in experimental transplant models: a review.
    Kaufman DB
    Transplant Proc; 1996 Apr; 28(2):868-70. PubMed ID: 8623440
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunosuppressive effects of FK 506 and 15-deoxyspergualin in rat lung transplantation.
    Katayama Y; Takao M; Onoda K; Hiraiwa T; Yada I; Namikawa S; Kusagawa M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):349-53. PubMed ID: 1703690
    [No Abstract]   [Full Text] [Related]  

  • 31. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
    Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
    [No Abstract]   [Full Text] [Related]  

  • 32. Establishment of rejection therapy with deoxyspergualin by multicentral controlled clinical studies in renal recipients.
    Amemiya H; Taguchi Y; Fukao K; Isono K; Omoto R; Ota K; Kosaki M; Takagi H; Oka T; Sonoda T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):730-3. PubMed ID: 8438462
    [No Abstract]   [Full Text] [Related]  

  • 33. 15-Deoxyspergualin--a new perspective of immunosuppressive therapy in experimental xenogeneic kidney transplantation (XKTP).
    Saumweber D; Singer T; Hammer C; Krombach F; Böhm D; Gokel J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):542. PubMed ID: 2650196
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
    Takahashi K; Ota K; Tanabe K; Oba S; Teraoka S; Toma H; Agishi T; Kawaguchi H; Ito K
    Transplant Proc; 1990 Aug; 22(4):1606-12. PubMed ID: 2389420
    [No Abstract]   [Full Text] [Related]  

  • 35. 15-Deoxyspergualin potentiates the immunosuppressive effect of cyclosporine A in a rat heart allograft model.
    Gannedahl G; Wanders A; Carlsson M; Tufveson G
    Transplant Proc; 1993 Feb; 25(1 Pt 1):768-9. PubMed ID: 8438473
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppression: deoxyspergualin.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):229-41. PubMed ID: 3347951
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunosuppressive effect and toxicity of 15-deoxyspergualin in cynomolgus monkey.
    Fukao K; Iwasaki H; Yuzawa K; Otsuka M; Yu Y; Sharma N; Iwasaki Y; Hori T; Murayama Y; Terao K
    Transplant Proc; 1991 Feb; 23(1 Pt 1):556-8. PubMed ID: 1824990
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of renal transplant rejection with 15-deoxyspergualin--a dose-finding study in man.
    Ohlman S; Gannedahl G; Tydén G; Tufveson G; Groth CG
    Transplant Proc; 1992 Feb; 24(1):318-20. PubMed ID: 1539294
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunosuppressive mechanisms of 15-deoxyspergualin on heterotopic heart transplantation in rats.
    Nakata S; Ito T; Shirakura R; Matsuda H; Fukuzawa M; Nakano S; Fukushima N; Kawashima Y
    Transplant Proc; 1991 Feb; 23(1 Pt 1):864-5. PubMed ID: 1825004
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of 15-deoxyspergualin on mononuclear cells from kidney recipients.
    Johansson-Borg A; Ohlman S; Groth CG
    Transplant Proc; 1992 Feb; 24(1):267-8. PubMed ID: 1539276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.